Thu, 18-Aug-2022
Friday 03 Apr 2020 , 6:26 am

Dilon Technologies Inc. Acquires the Dune Medical MarginProbe

As a global provider of breast cancer solutions, Dilon's Navigator Gamma Probes are used for radio-guided lymphatic mapping and tumor localization world-wide.
By SIN Bureau
Share at:

Dilon Technologies Inc., a leader in breast cancer treatment and diagnosis and owner of the Navigator Gamma Probes has acquired substantially all the assets of Dune Medical, including Dune Medical's "MarginProbe".

"With the acquisition of the MarginProbe, Dilon will now offer the only FDA approved device for identifying positive margins during breast conservation surgery.  MarginProbe's patented RF technology differentiates cancerous versus healthy tissue in real-time.  This allows surgeons to immediately remove additional tissue, helping to reduce avoidable surgeries" said Dilon's Chairman, Bob Moussa, who continued, "The synergy between Dilon's Navigator Gamma Probes and the MarginProbe will help patients and physicians answer the question, "did we get it all?" when that answer is most needed. In addition to the advantages to the patients, the reduction in re-excision rate will provide major savings to health care systems."

As a global provider of breast cancer solutions, Dilon's Navigator Gamma Probes are used for radio-guided lymphatic mapping and tumor localization world-wide.  "The combination of Dilon's class leading Navigator Gamma Probes with the MarginProbe is a natural fit.  Dilon's already strong sales network is synergistic and well suited to expand the MarginProbe's potential as the products are literally used side by side by the same physician; now they will be sold that way as well. The market in the United States alone exceeds $150m annually, and as a US based company, Dilon has a home field advantage in the MarginProbe's biggest market. Luminaries and thought leaders have already adopted MarginProbe as their standard of care in the US. Our goal is to make MarginProbe the standard of care worldwide."




Neha Mule

Neha writes articles on sectors including medicine, food, materials, and science & technology. A qualified statistician, she has the ability to observe and analyze the trends in global markets and write compelling articles that help CXOs in decision making. She is a bookworm and loves to read fiction, lifestyle, science and technology. Neha comes with 6 years of experience in content writing and editing that involves blog writing, preparation of study materials and OERs.

More from Neha Mule

Related News